Bicyclic Peptides with Optimized Ring Size Inhibit Human Plasma Kallikrein and its Orthologues While Sparing Paralogous Proteases

Vanessa Baeriswyl, Helen Rapley, Lisa Pollaro, Catherine Stace, Daniel P. Teufel, Edward H. Walker, Shiyu Chen, Greg Winter, John Tite, Christian Heinis

ChemMedChem · 2012 · 71 citations · 11 references

DOIFull text

Open access

Concepts

Abstract

Picky push-bikes! Bicyclic peptides with low to sub-nanomolar inhibitory activities towards the serine protease plasma kallikrein were developed. By modulating the size of the macrocyclic rings, inhibitors with the desired specificity profile could be generated.

References

11